Alemtuzumab, under the brand name Campath, was pulled from the leukaemia market ...
Sanofi has announced a significant investment of €1.3bn ($1.4bn) to expand its i...
GSK announced that Jemperli plus chemotherapy has obtained expanded FDA approval...
Merck KGaA has concluded the acquisition of Mirus Bio for €500m ($600m), enhanci...
AbbVie has completed its acquisition of all outstanding shares of Cerevel Therap...
Patients treated with Leqembi over three years have demonstrated a slowing of Al...
The company has fired 25% of staff and discontinued pipeline programs to funnel ...
The MAGE-A4-targeted genetically modified T cell therapy is indicated for the tr...
In 2023, Casgevy was approved in the US to treat sickle cell disease (SCD), maki...
The industry is seeking to scale up and satisfy demand for diabetes and obesity ...
How many patents did Bayer submit related to ecommerce last quarter, and how man...
How many patents did Bayer submit related to batteries last quarter, and how man...
How many patents did Amgen submit related to mobile last quarter, and how many w...
How many patents did Amgen submit related to internet of things last quarter, an...
Gene therapy research is expensive. Biotechs invest millions of dollars in early...
